Dr. Edmund Bartlett, MD
Claim this profileMemorial Sloan Kettering Cancer Centre
Studies Soft Tissue Sarcoma
Studies Dermatofibrosarcoma Protuberans
2 reported clinical trials
5 drugs studied
Area of expertise
1Soft Tissue Sarcoma
Stage IV
Stage III
2Dermatofibrosarcoma Protuberans
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Edmund Bartlett, MD is currently running
Intratumoral Tigilanol Tiglate
for Soft Tissue Sarcoma
A Phase IIa open label study evaluating the preliminary efficacy of intratumoural tigilanol tiglate in advanced and/or metastatic soft tissue sarcoma of the extremities and body wall.
Recruiting1 award Phase 2
Pembrolizumab + Local Chemotherapy
for Sarcoma
The purpose of this study is to find out whether giving the study drug pembrolizumab in combination with the chemotherapy drugs melphalan and dactinomycin, delivered directly to the affected arm or leg using a technique called isolated limb infusion (ILI), is a safe treatment that can delay the time before your disease gets worse (progresses).
Recruiting3 awards Phase 212 criteria
More about Edmund Bartlett, MD
Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Edmund Bartlett, MD has experience with
- Dactinomycin
- Isolated Limb Infusion
- Melphalan
- Pembrolizumab
- Tigilanol Tiglate
Breakdown of trials Edmund Bartlett, MD has run
Soft Tissue Sarcoma
Dermatofibrosarcoma Protuberans
Alveolar Soft Part Sarcoma
Soft tissue sarcoma
Malignant Fibrous Histiocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Edmund Bartlett, MD specialize in?
Edmund Bartlett, MD focuses on Soft Tissue Sarcoma and Dermatofibrosarcoma Protuberans. In particular, much of their work with Soft Tissue Sarcoma has involved Stage IV patients, or patients who are Stage III.
Is Edmund Bartlett, MD currently recruiting for clinical trials?
Yes, Edmund Bartlett, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Edmund Bartlett, MD has studied deeply?
Yes, Edmund Bartlett, MD has studied treatments such as Dactinomycin, Isolated Limb Infusion, Melphalan.
What is the best way to schedule an appointment with Edmund Bartlett, MD?
Apply for one of the trials that Edmund Bartlett, MD is conducting.
What is the office address of Edmund Bartlett, MD?
The office of Edmund Bartlett, MD is located at: Memorial Sloan Kettering Cancer Centre, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.